Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

The method produces finasteride with a 92% yield.

Alcoholic solvent improves selectivity in key intermediate for finasteride and dutasteride synthesis.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Zaleya pentandra extracts, especially acetone, may be useful for new medicines and food industry applications.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Polymers increased skin permeation and stability of steroid hormones in liposomal formulations.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

Methods for creating diverse ring-shaped molecules and their uses.

Phyllanthus emblica extract in ethosomes could potentially prevent hair loss.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Eucalyptus and Tween 80 most effectively increase cetirizine skin absorption.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Finasteride's two forms have different stability based on temperature and pressure.

The combined herbal extract formulation promotes hair growth safely without skin irritation.

Espumil foam base allows easy preparation of skin medications for hairy areas.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.